Transdermal NSAID Matches Oral Celecoxib After Knee Replacement - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Transdermal NSAID Matches Oral Celecoxib After Knee Replacement

Randomized trial finds a topical anti-inflammatory patch provided similar pain relief, function, and safety as oral therapy during the first 6 weeks after surgery.

  • By

  • Doug Brunk

  • July 2, 2026

  • 4 min

Share

Clinical Scorecard: Transdermal NSAID Matches Oral Celecoxib After Knee Replacement

At a Glance

CategoryDetail
ConditionPost-operative pain control after total knee arthroplasty
Key MechanismsTransdermal esflurbiprofen patch vs. oral celecoxib for pain management
Target PopulationPatients aged 50 years or older undergoing primary unilateral total knee arthroplasty for knee osteoarthritis
Care SettingSingle-center, prospective, randomized controlled trial

Key Highlights

  • Transdermal esflurbiprofen provided noninferior pain control compared to oral celecoxib.
  • Both treatments resulted in similar pain scores and functional recovery at 6 weeks.
  • No patients required rescue morphine in either treatment group.
  • Safety outcomes were comparable, with no serious adverse events reported.
  • Study limitations include small sample size and short treatment duration.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider transdermal esflurbiprofen as an alternative to oral celecoxib for post-operative pain control.

    Monitoring & Follow-up

    • Monitor kidney function at baseline, postoperative day 1, week 2, and week 6.

    Risks

    • Potential for unidentified rare side effects due to the study's limitations.

    Patient & Prescribing Data

    Patients aged 50 years or older undergoing total knee arthroplasty.

    Both transdermal esflurbiprofen and oral celecoxib were effective in managing post-operative pain.

    Clinical Best Practices

    • Implement multimodal pain management regimens including paracetamol and pregabalin.
    • Assess pain intensity using visual analog scale post-operatively.

    Related Resources & Content

    Original Source(s)

    Transdermal NSAID Matches Oral Celecoxib After Knee Replacement

    • by Doug Brunk

    • July 2, 2026

    Related Content

    Lower BMI, Lower Joint Replacement Risk?

    Researchers urge caution in interpreting joint replacement predictors, noting that surgery reflects access and decision-making as well as disease biology.

    CAA Use Tied to Higher Arthroplasty Risk

    In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.

    Coordinated Return-to-Work model reduces sickness absences after hip or knee arthroplasty: a registry-based study